Latest Articlesddd
AMGEN AND OSTEOPOROSIS Amgen And UCB Announce Positive Top-Line Results From The Phase 3 Study of Romosozumab …
On February 4, 2015, we wrote an article titled, “Aerie Pharmaceuticals is speeding towards improving the …
Regulus Pharmaceuticals (RGLS) a biopharmaceutical company that discovers, designs and develop treatments targeting microRNAs announced interim results from one …
Gilead Sciences Gilead (GILD) Shareholders wouldn’t expect to watch short investors make billions of dollars going …
Yes. Dana-Farber Cancer Institute and Array Pharmaceuticals (ARRY) announced an immuno-oncology collaboration with potential applicability in a wide …
Prohost Letter #391 Frightened by the Market and Politicians’ Debates, Not the Drug Industry, Investors are Fleeing …
Incyte: A Good Company Facing Irrelevant Investors’ Reaction Incyte decided to stop an early ongoing trial …
EXELIXIS Good News about CABO The FDA has determined that Exelixis’ (EXEL) cabozantinib New Drug Application (NDA) …
Halozyme Therapeutics (HALO) seems to have closed the previously announced $150 million royalty-backed debt transaction with investment …
Theravance Biopharma (TBPH) announced the commercial launch of VIBATIV® (telavancin) in Canada. VIBATIV is a once-daily antibiotic …
The Market is Surely Ignoring the Historical Summit Biotech achievements are standing on Right Now …
Escaping the slaughter, or taking advantage of it, or accumulating the stocks we love, or turning …
Prohost Letter #390 COMPANIES USING CRISPR GENE EDITING TOOLS - The Firms Launched with CRISPR Patents Either …
Of the Biotech Sector’s Selloff Testing the lows in biotech firms’ stock prices is nothing but …
The Evolution of Liquid Biopsy TWO PIANISTS, GUARDANT HEALTH and C4 THERAPEUTICS Biotech firms are bringing …
Improving the management of inflammatory and autoimmune diseases has been a dream that seems to be …
Exelixis Announces Positive Results from Subgroup Analyses of the METEOR Phase 3 Pivotal Trial of Cabozantinib …
On Oct. 28, 2015, Gilead Sciences (GILD) announced that it has submitted a New Drug Application …
The market looks like angry, probably very angry, as stocks are in a severe selloff mood. …
Prohost Letter #389 Happy New Year 2016 Wishing You Good Health Peace of Mind Love And …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
